Pursuant to Regulation 30 read with Schedule III of the SEBI Listing Regulations, Lupin has informed that Multicare Pharmaceuticals Philippines, Inc. (‘MPPI’), a subsidiary of Nanomi B.V., the Netherlands (‘Nanomi’), which is a wholly owned subsidiary of the Company, has bought back 2,813,811 equity shares from some of its existing shareholders. Nanomi did not participate in the said buyback. This has resulted in increase in the shareholding of Nanomi in MPPI from 51% to 56.28% effective today. The details required under Regulation 30 and Schedule III of SEBI Listing Regulations, read with the SEBI Master Circular dated January 30, 2026, bearing reference number HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 and such other circulars as applicable (‘SEBI Master Circular’), is set out at Annexure I.
.The above information is a part of company’s filings submitted to BSE.
